Molina Healthcare, Inc. (MOH) Director John C. Molina Sells 16,226 Shares

Molina Healthcare, Inc. (NYSE:MOH) Director John C. Molina sold 16,226 shares of the firm’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $92.49, for a total value of $1,500,742.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

John C. Molina also recently made the following trade(s):

  • On Monday, December 18th, John C. Molina sold 19,885 shares of Molina Healthcare stock. The shares were sold at an average price of $75.47, for a total value of $1,500,720.95.

Shares of Molina Healthcare, Inc. (MOH) traded down $1.94 during midday trading on Friday, hitting $91.83. 1,660,272 shares of the company were exchanged, compared to its average volume of 1,013,937. Molina Healthcare, Inc. has a fifty-two week low of $42.56 and a fifty-two week high of $93.98. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.06. The company has a market capitalization of $5,353.70, a PE ratio of -15.13, a P/E/G ratio of 1.12 and a beta of 0.97.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The company had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $4.95 billion. During the same quarter in the prior year, the firm earned $0.85 earnings per share. Molina Healthcare’s revenue for the quarter was up 10.7% compared to the same quarter last year. analysts expect that Molina Healthcare, Inc. will post -3.88 EPS for the current year.

A number of equities research analysts have issued reports on the company. Leerink Swann raised their target price on Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, January 9th. Jefferies Group raised their target price on Molina Healthcare from $60.00 to $64.00 and gave the company a “hold” rating in a research note on Friday, October 13th. Wolfe Research upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Morgan Stanley lifted their price objective on shares of Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Finally, BMO Capital Markets initiated coverage on shares of Molina Healthcare in a research note on Monday, October 16th. They set a “market perform” rating and a $70.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $70.86.

Large investors have recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. grew its holdings in Molina Healthcare by 33.9% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 8,958 shares of the company’s stock worth $616,000 after acquiring an additional 2,266 shares during the period. Tavio Capital LLC grew its holdings in Molina Healthcare by 418.0% during the third quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock worth $36,937,000 after acquiring an additional 433,485 shares during the period. Rothschild Asset Management Inc. grew its holdings in Molina Healthcare by 6.1% during the third quarter. Rothschild Asset Management Inc. now owns 706,683 shares of the company’s stock worth $48,592,000 after acquiring an additional 40,737 shares during the period. Jana Partners LLC grew its holdings in Molina Healthcare by 52.5% during the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after acquiring an additional 731,992 shares during the period. Finally, Legal & General Group Plc grew its holdings in Molina Healthcare by 25.8% during the third quarter. Legal & General Group Plc now owns 71,545 shares of the company’s stock worth $4,912,000 after acquiring an additional 14,682 shares during the period.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Week Herald and is the property of of Week Herald. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://weekherald.com/2018/01/20/molina-healthcare-inc-moh-director-john-c-molina-sells-16226-shares.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply